Search research articles
Contact Us
Filters
Showing results (191-200 of 204) with videos related to
Page
of 21
Sort By:
European Journal of Immunology
|
December 23, 1998
Double-stranded deoxyribonucleic acid binds to HLA class II molecules and inhibits HLA class II-mediated antigen presentation
G Filaci, P Contini, I Grasso, et al.
Melanoma Research
|
August 1, 1997
Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient
C Doucet, R Meazza, C Pottin-Clemenceau, et al.
Oncogene
|
November 7, 2000
IL-15/IL-15Ralpha intracellular trafficking in human melanoma cells and signal transduction through the IL-15Ralpha
R Pereno, J Giron-Michel, A Gaggero, et al.
Annals of the Rheumatic Diseases
|
January 15, 2004
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients
A Sulli, M Ghio, G P Bezante, et al.
Rheumatology (Oxford, England)
|
October 27, 1999
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy
G Filaci, M Cutolo, M Scudeletti, et al.
Clinical and Experimental Medicine
|
December 1, 2012
Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata
G Conteduca, A Rossi, F Megiorni, et al.
Transplantation
|
January 15, 1997
The presence of posttransplant HLA-specific IgG antibodies detected by enzyme-linked immunosorbent assay correlates with specific rejection pathologies
A N Costa, M P Scolari, S Iannelli, et al.
Annals of the New York Academy of Sciences
|
July 15, 2005
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation
G Filaci, M Rizzi, M Setti, et al.
Oncogene
|
March 7, 1996
IL2 triggers a tumor progression process in a melanoma cell line MELP derived from a patient whose metastasis increased in size during IL2/INFalpha biotherapy
D Han, C Pottin-Clemenceau, M A Imro, et al.
Oncogene
|
June 17, 1998
IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops
C Barzegar, R Meazza, R Pereno, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 204) with videos related to
Sort By:
Page
of 21
European Journal of Immunology
|
December 23, 1998
Double-stranded deoxyribonucleic acid binds to HLA class II molecules and inhibits HLA class II-mediated antigen presentation
G Filaci, P Contini, I Grasso, et al.
Melanoma Research
|
August 1, 1997
Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient
C Doucet, R Meazza, C Pottin-Clemenceau, et al.
Oncogene
|
November 7, 2000
IL-15/IL-15Ralpha intracellular trafficking in human melanoma cells and signal transduction through the IL-15Ralpha
R Pereno, J Giron-Michel, A Gaggero, et al.
Annals of the Rheumatic Diseases
|
January 15, 2004
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients
A Sulli, M Ghio, G P Bezante, et al.
Rheumatology (Oxford, England)
|
October 27, 1999
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy
G Filaci, M Cutolo, M Scudeletti, et al.
Clinical and Experimental Medicine
|
December 1, 2012
Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata
G Conteduca, A Rossi, F Megiorni, et al.
Transplantation
|
January 15, 1997
The presence of posttransplant HLA-specific IgG antibodies detected by enzyme-linked immunosorbent assay correlates with specific rejection pathologies
A N Costa, M P Scolari, S Iannelli, et al.
Annals of the New York Academy of Sciences
|
July 15, 2005
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation
G Filaci, M Rizzi, M Setti, et al.
Oncogene
|
March 7, 1996
IL2 triggers a tumor progression process in a melanoma cell line MELP derived from a patient whose metastasis increased in size during IL2/INFalpha biotherapy
D Han, C Pottin-Clemenceau, M A Imro, et al.
Oncogene
|
June 17, 1998
IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops
C Barzegar, R Meazza, R Pereno, et al.
Page
of 21